These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15138753)

  • 1. Cognitive skill learning in healthy older adults after 2 months of double-blind treatment with piribedil.
    Peretti CS; Gierski F; Harrois S
    Psychopharmacology (Berl); 2004 Nov; 176(2):175-81. PubMed ID: 15138753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
    Thobois S; Lhommée E; Klinger H; Ardouin C; Schmitt E; Bichon A; Kistner A; Castrioto A; Xie J; Fraix V; Pelissier P; Chabardes S; Mertens P; Quesada JL; Bosson JL; Pollak P; Broussolle E; Krack P
    Brain; 2013 May; 136(Pt 5):1568-77. PubMed ID: 23543483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the dopamine agonist piribedil on prefrontal temporal cortical network function in normal aging as assessed by verbal fluency.
    Gierski F; Peretti CS; Ergis AM
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):262-8. PubMed ID: 16876301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chlorpromazine and lorazepam on explicit memory, repetition priming and cognitive skill learning in healthy volunteers.
    Danion JM; Peretti S; Grangé D; Bilik M; Imbs JL; Singer L
    Psychopharmacology (Berl); 1992; 108(3):345-51. PubMed ID: 1523284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychomotor and cognitive effects of piribedil, a dopamine agonist, in young healthy volunteers.
    Schück S; Bentué-Ferrer D; Kleinermans D; Reymann JM; Polard E; Gandon JM; Allain H
    Fundam Clin Pharmacol; 2002 Feb; 16(1):57-65. PubMed ID: 11903513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of haloperidol and amisulpride on motor and cognitive skill learning in healthy volunteers.
    Peretti CS; Danion JM; Kauffmann-Muller F; Grangé D; Patat A; Rosenzweig P
    Psychopharmacology (Berl); 1997 Jun; 131(4):329-38. PubMed ID: 9226734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment.
    Nagaraja D; Jayashree S
    Am J Psychiatry; 2001 Sep; 158(9):1517-9. PubMed ID: 11532743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic insufficiency reflecting cerebral ageing: value of a dopaminergic agonist, piribedil.
    Ollat H
    J Neurol; 1992; 239 Suppl 1():S13-6. PubMed ID: 1634905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
    Brocco M; Dekeyne A; Papp M; Millan MJ
    Behav Pharmacol; 2006 Nov; 17(7):559-72. PubMed ID: 17021388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents.
    Marighetto A; Valerio S; Philippin JN; Bertaina-Anglade V; Drieu la Rochelle C; Jaffard R; Morain P
    J Psychopharmacol; 2008 Jul; 22(5):511-21. PubMed ID: 18308794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive skill learning and schizophrenia: implications for cognitive remediation.
    Michel L; Danion JM; Grangé D; Sandner G
    Neuropsychology; 1998 Oct; 12(4):590-9. PubMed ID: 9805329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
    Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
    Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A deficit in optimizing task solution but robust and well-retained speed and accuracy gains in complex skill acquisition in Parkinson׳s disease: multi-session training on the Tower of Hanoi Puzzle.
    Vakil E; Hassin-Baer S; Karni A
    Neuropsychologia; 2014 May; 57():12-9. PubMed ID: 24530238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tinnitus treatment with piribedil guided by electrocochleography and acoustic otoemissions.
    de Azevedo AA; Langguth B; de Oliveira PM; Rodrigues Figueiredo R
    Otol Neurotol; 2009 Aug; 30(5):676-80. PubMed ID: 19574947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulpiride and mnemonic function: effects of a dopamine D2 receptor antagonist on working memory, emotional memory and long-term memory in healthy volunteers.
    Mehta MA; Hinton EC; Montgomery AJ; Bantick RA; Grasby PM
    J Psychopharmacol; 2005 Jan; 19(1):29-38. PubMed ID: 15671126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of instances in cognitive skill learning: adult age differences.
    D'Eredita MA; Hoyer WJ
    Exp Aging Res; 2010; 36(1):23-39. PubMed ID: 20054725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stimulation of somatotropin hormone by piribedil, a dopaminergic agonist, in endogenous depression. Preliminary study].
    Guillaume R; Charles G; Mesters P; Schittecatte M; Wilmotte J
    Acta Psychiatr Belg; 1988; 88(2):153-61. PubMed ID: 2905110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study.
    Wagg A; Dale M; Tretter R; Stow B; Compion G
    Eur Urol; 2013 Jul; 64(1):74-81. PubMed ID: 23332882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive skill learning and aging: a component process analysis.
    Peretti CS; Danion JM; Gierski F; Grangé D
    Arch Clin Neuropsychol; 2002 Jul; 17(5):445-59. PubMed ID: 14591999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching from levodopa to the long-acting dopamine D2/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP-treated primates.
    Smith LA; Jackson MJ; Johnston L; Kuoppamaki M; Rose S; Al-Barghouthy G; Del Signore S; Jenner P
    Clin Neuropharmacol; 2006; 29(3):112-25. PubMed ID: 16772809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.